Archive summary Clinical
FDA clears first at-home brain device for depression
FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical stimulation for adults, available in 2026.
Section
Clinical & research
Depression, anxiety, trauma, substance use, dementia and emerging treatments, as reported by clinical and research outlets.
846 articles · page 15 of 22 · Jan 8, 2026 – Jan 21, 2026
Archive summary Clinical
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026
Market Analysis by covering: CorMedix Inc, ATAI Beckley Inc, Evommune Inc. Read 's Market Analysis on Investing.com
Archive summary Clinical
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure ...
Archive summary Clinical
VTGN Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ...
SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired…
Archive summary Clinical
2026 Asset Growth: Why Federal Compliance Is the New Metric
VANCOUVER, British Columbia, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – Consumer healthcare markets hit a massive $362 billion entering 2026,…
Archive summary Clinical
How depression in later life may herald Parkinson’s and dementia
(NaturalNews) A major Danish study found that depression in older adults can act as an early biological warning sign for Parkinson's disease and Lewy body demen...
Archive summary Clinical
Medical marijuana’s pain promise is under fire — again
The scientific review comes as Americans are increasingly turning to the plant to cope with chronic pain, sleep difficulties, anxiety and a wide range of other health…
Archive summary Clinical
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ:ATAI) ("AtaiBeckley" or "Company"), a clinical-stage biotechnology company on a mission to transform…
Archive summary Clinical
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date
WILMINGTON, Del., Jan. 16, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) (the "Company"), a clinical-stage biopharmaceutical company, today announced…
Archive summary Clinical
Rosen Law Firm Urges Vistagen Therapeutics, Inc. (NASDAQ: VTGN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Archive summary Clinical
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) INVESTOR ALERT Investors With Large Losses in ...
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the…
Archive summary Clinical
Compass Health Announces Opening Of Crisis Triage Center At Marc Healing Center, Offering 24/7 Behavioral Health Crisis Care To Community Members Regionwide
16-bed crisis triage center is the final program to launch in new state-of-the-art facility, following the December 2025 opening of the 16-bed Evaluation and ...
Archive summary Clinical
How singer Grace Gaustad is creating a safe haven for those suffering with anxiety, depression
Gaustad, 19, shares her mental health journey with Know Your Value. “It’s easier to struggle with someone else than to struggle alone,” she says.
Archive summary Clinical
Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards
MELBOURNE, Australia and NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing…
Archive summary Clinical
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine ...
NRX-100 (preservative-free ketamine) has been granted Fast Track Designation by FDA for treatment of suicidal ideation in patients with Depression and Bipolar…
Archive summary Clinical
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
NRX-100 (preservative-free ketamine) has been granted Fast Track Designation by FDA for treatment of suicidal ideation in patients with Depression and Bipolar…
Archive summary Clinical
Omniscient Secures New CPT® Code for Connectomic Analysis, Validating the Clinical Utility of Brain Network Mapping
Omniscient secures new AMA CPT® code for connectomic analysis, validating Quicktome’s clinical utility in brain care and advancing reimbursement.
Archive summary Clinical
Scouted: Red Light Therapy Offers a Slew of Unexpected Health Benefits, From Healing Cold Sores to Reducing Wrinkles
Yana Iskayeva / Getty ImagesScouted selects products independently. If you purchase something from our posts, we may earn a small commission.From facial masks that…
Archive summary Clinical
An Abnormally Slow Heart Rate Is Associated With Xylazine-Fentanyl Overdose; Primarily Seen in Northeastern United States
Breakthrough Mount Sinai study is the first to link this symptom to the novel synthetic drug in opioid overdose; findings can help doctors save lives during emergencies
Archive summary Clinical
GLP-1 Agonists as Therapeutics for Alzheimer's Disease: Not Right Now, but Maybe in the Future
Alzheimer's Disease affects over 7 million people in the United States, with approximately 1 in 9 patients aged 65 and older having the condition and most patients being…
Archive summary Clinical
Implant Provides Lasting Relief for Treatment-Resistant Depression
In a new study, WashU Medicine researchers show that vagus nerve stimulation from a small, implanted device provides substantial, long-lasting improvements for some…
Archive summary Clinical
Study Finds Non-Hallucinogenic Psilocybin Neural Receptor
Researchers report a novel target for treating depression and anxiety.
Archive summary Clinical
Study finds non-hallucinogenic psilocybin neural receptor: A novel target for treating depression and anxiety
Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to provide long-term treatment for depression and…
Archive summary Clinical
Surfing offers healing through exposure, belonging, and awe.
Explore how surf therapy uniquely supports PTSD recovery, combining sensory immersion, community, and graduated exposure to restore safety, joy, and connection.
Archive summary Clinical
Ballad to establish addiction treatment facility in Norton
Ballad Health last week announced plans to open a comprehensive addiction services center in Southwest Virginia.
Archive summary Clinical
BrainsWay Announces FDA Approval of Neurolief's ProlivTMRx Neuromodulation System for Major Depressive Disorder (MDD)
BURLINGTON, Mass. and JERUSALEM, Jan. 12, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced…
Archive summary Clinical
CCHR Calls On FDA To Act As Evidence Mounts Linking Antidepressants To Persistent Sexual Dysfunction
LOS ANGELES, Calif., Jan. 12, 2026 (SEND2PRESS NEWSWIRE) - The Citizens Commission on Human Rights International (CCHR), a 57-year mental health industry watchdog, is ...
Archive summary Clinical
Reunion Neuroscience Announces Program Updates and Highlights Anticipated 2026 Milestones
Aligned with U.S. Food and Drug Administration (FDA) on Registrational Path for RE104 in Postpartum Depression (PPD); On Track to Initiate Phase 3 Trial in 2026 -- --…
Archive summary Clinical
LSD shows promise for treating anxiety under study in Charleston
LSD became notorious during the drug culture of the 1960s as a powerful hallucinogen. But a form of that drug shows promise for treating anxiety and is now being tested…
Archive summary Clinical
Study reveal why chewing gum might actually help with focus and stress relief
Brain imaging studies shed light on why humans have chewed gum for 8,000 years with research showing chewing activates regions tied to attention and stress regulation.
Archive summary Clinical
Screaming + vomiting: ‘Scromiting’ is the mysterious cannabis syndrome becoming more common
The condition is rare but a study found the number of diagnosed cases is increasing.
Archive summary Clinical
Study finds pharmacists 21% more likely to commit suicide, stress a factor
Study finds pharmacists 21% more likely to commit suicide, stress a factor.
Archive summary Clinical
Why some people can’t stay away from alcohol, even when they know it’s hurting them
By Madeline Holcombe, CNN (CNN) — Researchers came to Dr. Chris Knowles’ school in England when he was 18 years old to run an experiment. They wanted to see which novice…
Archive summary Clinical
Heart condition? The psychologist will see you now
There is a link between mental health and heart health. That means treating anxiety, depression, or PTSD may help prolong your life.
Archive summary Clinical
Thrift Store. Clinic. Roller Rink. Center Becomes ‘Radical’ Lifeline Amid Homelessness, Drug Crises.
Located in the Lower 9th Ward, this abandoned building has become a community sanctuary and resource.
Archive summary Clinical
Ataibeckley Provides Update And Outlook For 2026 Ahead Of J.P. Morgan Healthcare Conference
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc (NASDAQ: ATAI) (–AtaiBeckley– or the–Company–), a clinical-stage biotechnology company on a mission to ...
Archive summary Clinical
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
Archive summary Clinical
Dietary guidelines declare war on processed foods and sugar, encourage more protein and dairy
The MAHA movement claims wins — fewer processed foods and seed oils, more beef and dairy products — as Kennedy discards 421 pages of scientific recommendations.
Archive summary Clinical
Opinion: Do Americans expect too much from drugs?
Archive summary Clinical
Tris Pharma Announces Acceptance Of New Publication Highlighting Promise Of Dual NOP-MOP (Dual-NMR) Agonists For The Treatment Of Moderate-To-Severe Pain
Preferential MOP agonists such as oxycodone are often required for effective management of moderate to severe pain but come with significant risks of addiction ...